Francois Brisebois
Stock Analyst at Oppenheimer
(1.08)
# 3,456
Out of 4,829 analysts
89
Total ratings
28.41%
Success rate
-15.5%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintains: Outperform | $3.5 → $4 | $0.36 | +1,011.11% | 2 | Mar 28, 2025 | |
| ABEO Abeona Therapeutics | Initiates: Outperform | $16 | $5.27 | +203.61% | 1 | Mar 5, 2025 | |
| OVID Ovid Therapeutics | Upgrades: Outperform | $4 | $0.29 | +1,278.83% | 1 | Jan 29, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Outperform | $65 → $72 | $44.76 | +60.86% | 7 | Jan 22, 2025 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Outperform | $20 | $6.15 | +225.20% | 4 | Dec 17, 2024 | |
| TRDA Entrada Therapeutics | Maintains: Outperform | $25 → $28 | $8.38 | +234.13% | 2 | Nov 6, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Outperform | $29 → $30 | $9.39 | +219.49% | 8 | Oct 31, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $143 → $163 | $38.35 | +325.03% | 4 | Oct 31, 2024 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Outperform | $56 → $59 | $34.06 | +73.25% | 5 | Oct 30, 2024 | |
| DYN Dyne Therapeutics | Reiterates: Outperform | $55 | $11.41 | +382.03% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $15 | $3.42 | +338.60% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $6 | $3.66 | +63.93% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $11 | $2.35 | +369.08% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $12.30 | +13.82% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $15 | $2.86 | +424.48% | 4 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $2.81 | +789.68% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $65 | $30.02 | +116.52% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.19 | +356.62% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $5 | $0.73 | +584.93% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $152 | $7.05 | +2,056.03% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $63 → $36 | $17.46 | +106.19% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $5 → $4 | $3.60 | +11.11% | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $60 | $0.24 | +25,004.60% | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7,200 → $5,400 | $3.84 | +140,689.99% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8.5 | $2.79 | +204.66% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $11 | $2.22 | +395.50% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $18 | $1.87 | +862.57% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $3.79 | +1,219.26% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,240 | $1.24 | +261,190.32% | 1 | Feb 4, 2020 |
Sensei Biotherapeutics
Mar 28, 2025
Maintains: Outperform
Price Target: $3.5 → $4
Current: $0.36
Upside: +1,011.11%
Abeona Therapeutics
Mar 5, 2025
Initiates: Outperform
Price Target: $16
Current: $5.27
Upside: +203.61%
Ovid Therapeutics
Jan 29, 2025
Upgrades: Outperform
Price Target: $4
Current: $0.29
Upside: +1,278.83%
Tarsus Pharmaceuticals
Jan 22, 2025
Maintains: Outperform
Price Target: $65 → $72
Current: $44.76
Upside: +60.86%
Mind Medicine (MindMed)
Dec 17, 2024
Reiterates: Outperform
Price Target: $20
Current: $6.15
Upside: +225.20%
Entrada Therapeutics
Nov 6, 2024
Maintains: Outperform
Price Target: $25 → $28
Current: $8.38
Upside: +234.13%
Avadel Pharmaceuticals
Oct 31, 2024
Maintains: Outperform
Price Target: $29 → $30
Current: $9.39
Upside: +219.49%
Praxis Precision Medicines
Oct 31, 2024
Maintains: Outperform
Price Target: $143 → $163
Current: $38.35
Upside: +325.03%
Harmony Biosciences Holdings
Oct 30, 2024
Reiterates: Outperform
Price Target: $56 → $59
Current: $34.06
Upside: +73.25%
Dyne Therapeutics
Sep 3, 2024
Reiterates: Outperform
Price Target: $55
Current: $11.41
Upside: +382.03%
Aug 19, 2024
Reiterates: Outperform
Price Target: $15
Current: $3.42
Upside: +338.60%
Aug 16, 2024
Reiterates: Outperform
Price Target: $6
Current: $3.66
Upside: +63.93%
Aug 15, 2024
Reiterates: Outperform
Price Target: $11
Current: $2.35
Upside: +369.08%
Aug 14, 2024
Reiterates: Outperform
Price Target: $14
Current: $12.30
Upside: +13.82%
Jun 26, 2024
Maintains: Outperform
Price Target: $11 → $15
Current: $2.86
Upside: +424.48%
Jun 25, 2024
Initiates: Outperform
Price Target: $25
Current: $2.81
Upside: +789.68%
Jun 13, 2024
Maintains: Outperform
Price Target: $55 → $65
Current: $30.02
Upside: +116.52%
May 6, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.19
Upside: +356.62%
Apr 1, 2024
Reiterates: Outperform
Price Target: $5
Current: $0.73
Upside: +584.93%
Aug 30, 2023
Reiterates: Outperform
Price Target: $152
Current: $7.05
Upside: +2,056.03%
Aug 17, 2023
Maintains: Outperform
Price Target: $63 → $36
Current: $17.46
Upside: +106.19%
Apr 4, 2023
Maintains: Outperform
Price Target: $5 → $4
Current: $3.60
Upside: +11.11%
Apr 3, 2023
Maintains: Outperform
Price Target: $100 → $60
Current: $0.24
Upside: +25,004.60%
Feb 6, 2023
Maintains: Outperform
Price Target: $7,200 → $5,400
Current: $3.84
Upside: +140,689.99%
Sep 7, 2022
Initiates: Outperform
Price Target: $8.5
Current: $2.79
Upside: +204.66%
Aug 29, 2022
Maintains: Outperform
Price Target: $17 → $11
Current: $2.22
Upside: +395.50%
Jul 18, 2022
Assumes: Outperform
Price Target: $18
Current: $1.87
Upside: +862.57%
Oct 29, 2021
Initiates: Outperform
Price Target: $50
Current: $3.79
Upside: +1,219.26%
Feb 4, 2020
Initiates: Buy
Price Target: $3,240
Current: $1.24
Upside: +261,190.32%